Targeted radiopharmaceutical therapies ensure that radioactive agents are delivered directly to malignant cells while minimizing collateral damage to healthy tissue. The appointment of Dr. Amir Iravani as the Director of the Theranostics Program and Vice Chair of Clinical Research at UCLA Health
Building on its existing enterprise-grade operating system, Aidoc’s new investigational tool integrates generative AI directly into the workflows used by medical professionals. This represents a fundamental shift in diagnostic radiology by moving beyond simple flagging of abnormalities toward
Recent clinical findings indicate that nearly half of patients with an initial negative scan undergo significant treatment modifications following a second imaging attempt. This discovery challenged the traditional reliance on a single diagnostic window, highlighting a critical blind spot in the
With only 23% of the world’s 1.4 billion hypertensive adults having their condition under control, the demand for advanced circulatory visualization has never been more critical. The landscape of cardiovascular medicine is currently undergoing a profound transformation, fueled by a synergy of
Urologists are increasingly looking toward theranostics to resolve the clinical dilemma of equivocal MRI findings that currently lead to a high volume of redundant tissue samplings. This shift reflects a broader commitment to precision medicine, where the objective is to replace invasive,
Medical professionals currently face the challenge of transporting unstable stroke patients to radiology suites, a hurdle that portable electromagnetic imaging is designed to solve. EMvision Medical Devices has emerged as a leader in this transition, moving neurological diagnostics from heavy,